Home/Filings/4/0001415889-21-006188
4//SEC Filing

Hall Brett Matthew 4

Accession 0001415889-21-006188

CIK 0001790340other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 5:30 PM ET

Size

5.0 KB

Accession

0001415889-21-006188

Insider Transaction Report

Form 4
Period: 2021-12-22
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Class A Common Stock

    2021-12-22+322,691329,084 total
Footnotes (1)
  • [F1]Calculated using a value based on the average of the daily volume weighted average prices of the Class A common stock on the Nasdaq Stock Exchange for the 30-trading day period ending on and including the trading day immediately prior to the Closing Date, as that term is defined in the Share Purchase Agreement, dated as of December 22, 2021, by and among Immuneering Corporation, BioArkive, Inc. ("BioArkive"), and each of the shareholders of BioArkive, including Dr. Hall.

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001870437

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:30 PM ET
Size
5.0 KB